# Paramount Gold Nevada Corp.: financial statements, quarterly

PZG · NYSE · CIK 1629210 · [Materials](/sectors/materials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/pzg.md) · [Financials](/companies/pzg/financials.md) · [Filings](/companies/pzg/filings.md) · [Insiders](/companies/pzg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pzg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(2,028)](/filings/0000950170-24-125424.md) | [(2,613)](/filings/0000950170-25-018900.md) | [(2,201)](/filings/0000950170-25-069293.md) | [(1,654) d](/filings/0001193125-25-217759.md) | [(1,405)](/filings/0001193125-25-281737.md) | [(1,219)](/filings/0001193125-26-044779.md) | [(2,196)](/filings/0001193125-26-219477.md) | [(2,136) d](/filings/0001193125-26-394400.md) | [(1,525)](/filings/0001193125-25-281737.md) | [(2,147)](/filings/0001193125-26-044779.md) | [(2,357)](/filings/0001193125-26-219477.md) | [(2,303) d](/filings/0001193125-26-394400.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(2,074)](/filings/0000950170-25-069293.md) | [(1,575)](/filings/0000950170-25-069293.md) | [(1,814)](/filings/0000950170-25-069293.md) | [(2,594) d](/filings/0001193125-25-217759.md) | [(1,572)](/filings/0001193125-26-219477.md) | [(2,031)](/filings/0001193125-26-219477.md) | [(2,618)](/filings/0001193125-26-219477.md) | [(2,828) d](/filings/0001193125-26-394400.md) | [(4,324)](/filings/0001193125-26-219477.md) | [(4,427)](/filings/0001193125-26-219477.md) | [(4,903)](/filings/0001193125-26-219477.md) | [(1,906) d](/filings/0001193125-26-394400.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0000950170-24-125424.md) | [(0.03)](/filings/0000950170-25-018900.md) | [(0.03)](/filings/0000950170-25-069293.md) | not reported | [(0.02)](/filings/0001193125-25-281737.md) | [(0.03)](/filings/0001193125-26-044779.md) | [(0.04)](/filings/0001193125-26-219477.md) | not reported | [(0.06)](/filings/0001193125-25-281737.md) | [(0.06)](/filings/0001193125-26-044779.md) | [(0.06)](/filings/0001193125-26-219477.md) | not reported |
| Basic EPS | $ per share | [(0.04)](/filings/0000950170-24-125424.md) | [(0.03)](/filings/0000950170-25-018900.md) | [(0.03)](/filings/0000950170-25-069293.md) | not reported | [(0.02)](/filings/0001193125-25-281737.md) | [(0.03)](/filings/0001193125-26-044779.md) | [(0.04)](/filings/0001193125-26-219477.md) | not reported | [(0.06)](/filings/0001193125-25-281737.md) | [(0.06)](/filings/0001193125-26-044779.md) | [(0.06)](/filings/0001193125-26-219477.md) | not reported |

- Revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.0](/filings/0000950170-23-062083.md) | [8.6](/filings/0000950170-24-014581.md) | [7.0](/filings/0000950170-24-059575.md) | [5.4](/filings/0001193125-25-217759.md) | [4.3](/filings/0000950170-24-125424.md) | [3.4](/filings/0000950170-25-018900.md) | [2.1](/filings/0000950170-25-069293.md) | [1.4](/filings/0001193125-26-394400.md) | [4.2](/filings/0001193125-25-281737.md) | [3.5](/filings/0001193125-26-044779.md) | [12.7](/filings/0001193125-26-219477.md) | [9.9](/filings/0001193125-26-394400.md) |
| Current assets | $m | [2.5](/filings/0000950170-23-062083.md) | [9.4](/filings/0000950170-24-014581.md) | [7.8](/filings/0000950170-24-059575.md) | [6.7](/filings/0001193125-25-217759.md) | [5.3](/filings/0000950170-24-125424.md) | [4.2](/filings/0000950170-25-018900.md) | [2.8](/filings/0000950170-25-069293.md) | [2.7](/filings/0001193125-26-394400.md) | [5.1](/filings/0001193125-25-281737.md) | [4.2](/filings/0001193125-26-044779.md) | [13.2](/filings/0001193125-26-219477.md) | [11.2](/filings/0001193125-26-394400.md) |
| Total assets | $m | [54.5](/filings/0000950170-23-062083.md) | [61.4](/filings/0000950170-24-014581.md) | [59.9](/filings/0000950170-24-059575.md) | [56.4](/filings/0001193125-25-217759.md) | [55.0](/filings/0000950170-24-125424.md) | [53.9](/filings/0000950170-25-018900.md) | [52.6](/filings/0000950170-25-069293.md) | [52.4](/filings/0001193125-26-394400.md) | [54.8](/filings/0001193125-25-281737.md) | [53.9](/filings/0001193125-26-044779.md) | [62.9](/filings/0001193125-26-219477.md) | [60.8](/filings/0001193125-26-394400.md) |
| Current liabilities | $m | [10.2](/filings/0000950170-23-062083.md) | [4.3](/filings/0000950170-24-014581.md) | [3.5](/filings/0000950170-24-059575.md) | [0.7](/filings/0001193125-25-217759.md) | [0.5](/filings/0000950170-24-125424.md) | [0.5](/filings/0000950170-25-018900.md) | [0.7](/filings/0000950170-25-069293.md) | [0.7](/filings/0001193125-26-394400.md) | [3.9](/filings/0001193125-25-281737.md) | [4.1](/filings/0001193125-26-044779.md) | [4.9](/filings/0001193125-26-219477.md) | [3.6](/filings/0001193125-26-394400.md) |
| Total liabilities | $m | [12.4](/filings/0000950170-23-062083.md) | [20.7](/filings/0000950170-24-014581.md) | [20.4](/filings/0000950170-24-059575.md) | [18.2](/filings/0001193125-25-217759.md) | [17.9](/filings/0000950170-24-125424.md) | [18.3](/filings/0000950170-25-018900.md) | [18.6](/filings/0000950170-25-069293.md) | [18.8](/filings/0001193125-26-394400.md) | [23.3](/filings/0001193125-25-281737.md) | [25.4](/filings/0001193125-26-044779.md) | [27.6](/filings/0001193125-26-219477.md) | [26.9](/filings/0001193125-26-394400.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [42.1](/filings/0000950170-25-069293.md) | [40.8](/filings/0000950170-25-069293.md) | [39.5](/filings/0000950170-25-069293.md) | [38.2](/filings/0001193125-26-394400.md) | [37.1](/filings/0001193125-26-219477.md) | [35.5](/filings/0001193125-26-219477.md) | [34.0](/filings/0001193125-26-219477.md) | [33.6](/filings/0001193125-26-394400.md) | [31.5](/filings/0001193125-26-219477.md) | [28.5](/filings/0001193125-26-219477.md) | [35.3](/filings/0001193125-26-219477.md) | [33.9](/filings/0001193125-26-394400.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(899)](/filings/0000950170-24-125424.md) | [(628) d](/filings/0000950170-25-018900.md) | [(1,538) d](/filings/0000950170-25-069293.md) | [(2,345) d](/filings/0001193125-25-217759.md) | [(1,167)](/filings/0001193125-25-281737.md) | [(895) d](/filings/0001193125-26-044779.md) | [(1,501) d](/filings/0001193125-26-219477.md) | [(2,703) d](/filings/0001193125-26-394400.md) | [(1,081)](/filings/0001193125-25-281737.md) | [(1,398) d](/filings/0001193125-26-044779.md) | [(2,035) d](/filings/0001193125-26-219477.md) | [(2,770) d](/filings/0001193125-26-394400.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [46.9](/filings/0000950170-23-062083.md) | [47.0](/filings/0000950170-24-014581.md) | [48.5](/filings/0000950170-24-059575.md) | [56.3](/filings/0000950170-24-125424.md) | [59.1](/filings/0000950170-25-018900.md) | [60.5](/filings/0000950170-25-069293.md) | [65.2](/filings/0001193125-25-281737.md) | [66.2](/filings/0001193125-26-044779.md) | [67.9](/filings/0001193125-26-219477.md) | [76.3](/filings/0001193125-25-281737.md) | [78.4](/filings/0001193125-26-044779.md) | [83.1](/filings/0001193125-26-219477.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 86,215,381 at 2026-09-15, from the cover of the [10-K filed 2026-09-17](/filings/0001193125-26-394400.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.